Iron, Neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
Abstract
Information on the molecular distribution and ageing trend of brain iron in post-mortem material from normal subjects is scarce. Because it is known that neuromelanin and ferritin form stable complexes with iron(III), in this study we measured the concentration of iron, ferritin and neuromelanin in substantia nigra from normal subjects, aged between 1 and 90 years, dissected post mortem. Iron levels in substantia nigra were 20 ng/mg in the first year of life, had increased to 200 ng/mg by the fourth decade and remained stable until 90 years of age. The H-ferritin concentration was also very low (29 ng/mg) during the first year of life but increased rapidly to values of approximately 200 ng/mg at 20 years of age, which then remained constant until the eighth decade of life. L-Ferritin also showed an increasing trend during life although the concentrations were approximately 50% less than that of H-ferritin at each age point. Neuromelanin was not detectable during the first year, increased to approximately 1000 ng/mg in the second decade and then increased continuously to 3500 ng/mg in the 80th year. A Mössbauer study revealed that the high-spin trivalent iron is probably arranged in a ferritin-like iron--oxyhydroxide cluster form in the substantia nigra. Based on this data and on the low H- and L-ferritin content in neurones it is concluded that neuromelanin is the major iron storage in substantia nigra neurones in normal individuals.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [5]
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · see citing works
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650 · see citing works
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · see citing works
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works
Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 850 · see citing works
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754 · see citing works
Aging and Extrapyramidal Function
McGeer, P. L., McGeer, E. G., & Suzuki, J. S. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500130053010 · Cited by 648 · see citing works
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472 · see citing works
Inorganic Biochemistry of Iron Metabolism: From Molecular Mechanisms to Clinical Consequences
Crichton, R. (2001) · doi:10.1002/0470845791 · Cited by 453 · see citing works
Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445 · see citing works
Self-citationGood, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427 · see citing works
(1999) · PubMed · Cited by 425 · see citing works
Pakkenberg, B., Møller, A., Gundersen, H. J. G., Dam, A. M., & Pakkenberg, H. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.30 · Cited by 408 · see citing works
Spencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373 · see citing works
Mössbauer Spectroscopy and Transition Metal Chemistry
Gütlich, P., Link, R., & TRAUTWEIN, A. X. (1978) · Inorganic chemistry concepts · doi:10.1007/978-3-662-12545-8 · Cited by 347 · see citing works
Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334 · see citing works
Connor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., & LeWitt, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020717.x · Cited by 317 · see citing works
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313 · see citing works
Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin
D’Amato, R. J., Lipman, Z. P., & Snyder, S. H. (1986) · Science · doi:10.1126/science.3080808 · Cited by 296 · see citing works
Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease
Ben‐Shachar, D., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06358.x · Cited by 287 · see citing works
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284 · see citing works
Self-citationDecreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258 · see citing works
Iron in the basal ganglia in Parkinson's disease
Griffiths, P. D., Dobson, B. R., Jones, G. R., & Clarke, D. T. (1999) · Brain · doi:10.1093/brain/122.4.667 · Cited by 229 · see citing works
Kästner, A., Hirsch, É. C., Lejeune, O., Javoy-Agid, F., Rascol, O., & Agid, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08350.x · Cited by 228 · see citing works
Developmental changes in transferrin and iron uptake by the brain in the rat
Taylor, E. M., & Morgan, E. H. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90103-6 · Cited by 221 · see citing works
LIPOPROTEIN PIGMENTS—THEIR RELATIONSHIP TO AGEING IN THE HUMAN NERVOUS SYSTEM
Mann, D. M. A., & Yates, P. O. (1974) · Brain · doi:10.1093/brain/97.1.489 · Cited by 214 · see citing works
Tyrosine mRNA is expressed in human substantia nigra
Xu, Y., Stokes, A. H., Freeman, W. M., Kumer, S. C., Vogt, B. A., & Vrana, K. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00308-7 · Cited by 205 · see citing works
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., & Swartz, H. M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00047-4 · Cited by 197 · see citing works
Bartzokis, G., & Tishler, T. A. (2000) · PubMed · Cited by 196 · see citing works
Isoforms of ferritin have a specific cellular distribution in the brain
Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179 · see citing works
TRAUTWEIN, A. X., Bill, E., Bominaar, E. L., & WINKLER, H. (1991) · Structure and bonding · doi:10.1007/3-540-54261-2_1 · Cited by 175 · see citing works
Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain
Zecca, L., Pietra, R., Goj, C., Mecacci, C., Radice, D., & Sabbioni, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031097.x · Cited by 163 · see citing works
Preservation of midbrain catecholaminergic neurons in very old human subjects
Kubis, N., Faucheux, B. A., Ransmayr, G. N., Damier, P., Duyckaerts, C. J., Hénin, D., Forette, B., Charpentier, Y. L., Hauw, J., Agid, Y., et al. (2000) · Brain · doi:10.1093/brain/123.2.366 · Cited by 157 · see citing works
Gibb, W. R. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90719-p · Cited by 152 · see citing works
Mössbauer spectroscopic studies of human haemosiderin and ferritin
Bell, S. H., Weir, M., Dickson, D. P. E., Gibson, J. F., Sharp, G. A., & Peters, T. J. (1984) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(84)90313-3 · Cited by 151 · see citing works
Shima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135 · see citing works
Zhang, F., & Dryhurst, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a006 · Cited by 129 · see citing works
Total and paramagnetic metals in human substantia nigra and its neuromelanin
Zecca, L., & Swartz, H. M. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257675 · Cited by 123 · see citing works
Altered systemic iron metabolism in Parkinson's disease
Logroscino, G., Marder, K. S., Graziano, J. H., Freyer, G. A., Slavkovich, V. N., LoIacono, N. J., Cote, L. J., & Mayeux, R. P. (1997) · Neurology · doi:10.1212/wnl.49.3.714 · Cited by 118 · see citing works
Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin
Lindquist, N. G., Larsson, B. S., & Lydén‐Sokolowski, A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90002-x · Cited by 114 · see citing works
Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra
Gerlach, M., TRAUTWEIN, A. X., Zecca, L., Youdim, M. B. H., & Riederer, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020923.x · Cited by 114 · see citing works
Inorganic biochemistry of iron metabolism
Eastham, B. (1992) · Biochemical Education · doi:10.1016/0307-4412(92)90222-8 · Cited by 109 · see citing works
New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain
Tief, K., Schmidt, A., & Beermann, F. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00301-x · Cited by 105 · see citing works
Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study
Gałązka-Friedman, J., Bauminger, E. R., Friedman, A., Barcikowska, M., Hechel, D., & Nowik, I. (1996) · Movement Disorders · doi:10.1002/mds.870110104 · Cited by 102 · see citing works
The chemical characterization of melanin contained in substantia nigra of human brain
Zecca, L., Mecacci, C., Seraglia, R., & Parati, E. A. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90144-c · Cited by 101 · see citing works
Muthane, U. B., Yasha, T. C., & Shankar, S. K. (1998) · Annals of Neurology · doi:10.1002/ana.410430304 · Cited by 97 · see citing works
Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides
Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M., & Sonnino, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741758.x · Cited by 95 · see citing works
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies
Luzzago, A., Arosio, P., Iacobello, C., Ruggeri, G., Capucci, L., Brocchi, E., Simone, F., Gamba, D., Gabri, E., Levi, S., et al. (1986) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(86)90147-0 · Cited by 93 · see citing works
Offen, D. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00150-7 · Cited by 90 · see citing works
Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines
Matsunaga, J., Sinha, D., Pannell, L., Santis, C., Solano, F., Wistow, G. J., & Hearing, V. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3268 · Cited by 85 · see citing works
The Development of the Blood-Brain Barrier
Dobbing, J. (1968) · Progress in brain research · doi:10.1016/s0079-6123(08)64172-2 · Cited by 81 · see citing works
On the function of neuromelanin
Smythies, J. (1996) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1996.0073 · Cited by 76 · see citing works
Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?
Ikemoto, K., Nagatsu, I., Ito, S., King, R. A., Nishimura, A., & Nagatsu, T. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00649-1 · Cited by 74 · see citing works
Modulation by neuromelanin of the availability and reactivity of metal ions
Swartz, H. M., Sarna, T., & Zecca, L. (1992) · Annals of Neurology · doi:10.1002/ana.410320712 · Cited by 73 · see citing works
Shen, X.-M., Xia, B., Wrona, M. Z., & Dryhurst, G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960052v · Cited by 67 · see citing works
Q-band EPR investigations of neuromelanin in control and Parkinson’s disease patients
Lopiano, L., Chiesa, M., Digilio, G., Giraudo, S., Bergamasco, B., Torre, E., & Fasano, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00116-7 · Cited by 50 · see citing works
Kropf, A. J., Bunker, B. A., Eisner, M., Moss, S. C., Zecca, L., Stroppolo, A., & Crippa, P. R. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77755-0 · Cited by 43 · see citing works
Transient overexpression of human H- and L-ferritin chains in COS cells
Corsi, B., Perrone, F., Bourgeois, M., Beaumont, C., Panzeri, C., Cozzi, A., Sangregorio, R., Santambrogio, P., Albertini, A., Arosio, P., et al. (1998) · Biochemical Journal · doi:10.1042/bj3300315 · Cited by 43 · see citing works
The distribution of iron in the brain: A phylogenetic analysis using iron histochemistry
Erb, G. L., Osterbur, D., & LeVine, S. M. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00020-x · Cited by 35 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · see citing works
The physical and chemical properties of eumelanin
Meredith, P., & Sarna, T. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00345.x · Cited by 1,033 · see citing works
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667 · see citing works
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659 · see citing works
Self-citationGenetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · see citing works
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 580 · see citing works
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495 · see citing works
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I. B., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 499 · see citing works
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · see citing works
Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells
Crichton, R. R., Wilmet, S., Legssyer, R., & Ward, R. J. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00461-0 · Cited by 494 · see citing works
Ferroptosis and Its Role in Diverse Brain Diseases
Weiland, A., Wang, Y., Wu, W., Lan, X., Han, X., Li, Q., & Wang, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1403-3 · Cited by 469 · see citing works
Pang, S. Y.-Y., Ho, P. W., Liu, H., Leung, C.-T., Li, L., Chang, E. E. S., Ramsden, D. B., & Ho, S. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0165-9 · Cited by 433 · see citing works
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411 · see citing works
Brain iron pathways and their relevance to Parkinson's disease
Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362 · see citing works
Hong, L., & Simon, J. D. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp071439h · Cited by 360 · see citing works
Metals and amyloid‐β in Alzheimer's disease
Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., & Li, Q. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00434.x · Cited by 353 · see citing works
Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K. T., Masters, C. L., Bush, A. I., & Li, Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204379200 · Cited by 352 · see citing works
The relevance of iron in the pathogenesis of Parkinson’s disease
Sian‐Hülsmann, J., Mandel, S. A., Youdim, M. B. H., & Riederer, P. F. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 349 · see citing works
Fedorow, H., Tribl, F., Halliday, G. M., Gerlach, M., Riederer, P. F., & Double, K. L. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.001 · Cited by 347 · see citing works
The Relevance of Iron in the Pathogenesis of Parkinson's Disease
Götz, M. E., Double, K. L., Gerlach, M., Youdim, M. B. H., & RIEDERERE, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.017 · Cited by 342 · see citing works
Wilms, H., Rosenstiel, P. C., Sievers, J., Deuschl, G., Zecca, L., & Lucius, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0314fje · Cited by 337 · see citing works
Iron in Neurodegeneration – Cause or Consequence?
Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00180 · Cited by 298 · see citing works
Zecca, L., Fariello, R. G., Riederer, P. F., Sulzer, D. L., Gatti, A., & Tampellini, D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03269-0 · Cited by 287 · see citing works
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 281 · see citing works
Wang, Y., Spincemaille, P., Liu, Z., Dimov, A., Deh, K., Li, J., Zhang, Y., Yao, Y., Gillen, K. M., Wilman, A. H., et al. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25693 · Cited by 278 · see citing works
Sulzer, D. L., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J. A., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0047-3 · Cited by 277 · see citing works
The role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266 · see citing works
Zecca, L., Zucca, F. A., Wilms, H., & Sulzer, D. L. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.009 · Cited by 265 · see citing works
The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases
Dušek, P., Roos, P. M., Litwin, T., Schneider, S. A., Flaten, T. P., & Aaseth, J. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.007 · Cited by 253 · see citing works
Labandeira-García, J. L., Rodriguez-Perez, A. I., Garrido‐Gil, P., Rodríguez‐Pallares, J., Lanciego, J. L., & Guerra, M. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00129 · Cited by 251 · see citing works
Yokel, R. A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-102-309 · Cited by 246 · see citing works
Weinreb, O., Amit, T., Mandel, S. A., & Youdim, M. B. H. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0143-4 · Cited by 244 · see citing works
Neuromelanin of the Human Substantia Nigra: An Update
Zucca, F. A., Basso, E., Cupaioli, F. A., Ferrari, E., Sulzer, D., Casella, L., & Zecca, L. (2014) · Neurotoxicity Research · doi:10.1007/s12640-013-9435-y · Cited by 243 · see citing works
Miller, C. L., Llenos, I. C., Dulay, J. R., & Weis, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.056 · Cited by 240 · see citing works
Brain iron metabolism: Neurobiology and neurochemistry
Ke, Y., & Qian, Z. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236 · see citing works
Faucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229 · see citing works
NCOA4-Mediated Ferritinophagy: A Potential Link to Neurodegeneration
Quiles del Rey, M., & Mancias, J. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00238 · Cited by 227 · see citing works
Berg, D., Youdim, M. B. H., & Riederer, P. F. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 217 · see citing works
Zecca, L., Berg, D., Arzberger, T., Ruprecht, P., Rausch, W. D., Musicco, M., Tampellini, D., Riederer, P., Gerlach, M., & Becker, G. (2005) · Movement Disorders · doi:10.1002/mds.20550 · Cited by 214 · see citing works
Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease
Jakaria, M., Belaidi, A. A., Bush, A. I., & Ayton, S. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15519 · Cited by 212 · see citing works
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
Zecca, L., Tampellini, D., Gerlach, M., Riederer, P. F., Fariello, R. G., & Sulzer, D. L. (2001) · Europe PMC (PubMed Central) · doi:10.1136/mp.54.6.414 · Cited by 200 · see citing works
Decreased transferrin receptor expression by Neuromelanin cells in restless legs syndrome
Connor, J. R., Wang, X. S., Patton, S. M., Menzies, S. L., Troncoso, J. C., Earley, C. J., & Allen, R. P. (2004) · Neurology · doi:10.1212/01.wnl.0000123251.60485.ac · Cited by 199 · see citing works
Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study
Xu, X., Wang, Q., & Zhang, M. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.11.017 · Cited by 194 · see citing works
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Weinreb, O., Mandel, S. A., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 190 · see citing works
Iron metabolism in Parkinsonian syndromes
Berg, D., & Hochstrasser, H. (2006) · Movement Disorders · doi:10.1002/mds.21020 · Cited by 185 · see citing works
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Isaias, I. U., Trujillo, P., Summers, P. E., Marotta, G., Mainardi, L. T., Pezzoli, G., Zecca, L., & Costa, A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00196 · Cited by 186 · see citing works
Liu, Y., & Simon, J. D. (2003) · Pigment Cell Research · doi:10.1046/j.1600-0749.2003.00098.x · Cited by 185 · see citing works
Iron-binding characteristics of neuromelanin of the human substantia nigra
Double, K. L., Gerlach, M., Schünemann, V., TRAUTWEIN, A. X., Zecca, L., Gallorini, M., Youdim, M. B. H., Riederer, P. F., & Ben‐Shachar, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00293-4 · Cited by 182 · see citing works
Ishii, T., Warabi, E., & Mann, G. E. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.002 · Cited by 177 · see citing works
Iron dysregulation in movement disorders
Dušek, P., Jankovic, J. J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 172 · see citing works
Proteome analysis of human substantia nigra in Parkinson's disease
Werner, C. J., Haußen, R. H., Mall, G., & Wolf, S. (2008) · Proteome Science · doi:10.1186/1477-5956-6-8 · Cited by 167 · see citing works
Ayton, S., & Lei, P. (2014) · BioMed Research International · doi:10.1155/2014/581256 · Cited by 161 · see citing works
Ashraf, A., Clark, M., & So, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00065 · Cited by 158 · see citing works
Recent developments in the pathology of Parkinson’s disease
Jellinger, K. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_33 · Cited by 154 · see citing works
Contrast mechanisms associated with neuromelanin‐MRI
Trujillo, P., Summers, P. E., Ferrari, E., Zucca, F. A., Sturini, M., Mainardi, L. T., Cerutti, S., Smith, A. K., Smith, S. A., Zecca, L., et al. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26584 · Cited by 154 · see citing works
Ion‐Exchange and Adsorption of Fe(III) by Sepia Melanin
Liu, Y., Hong, L., Kempf, V. R., Wakamatsu, K., Ito, S., & Simon, J. D. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00140.x · Cited by 153 · see citing works
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Ma, L., Azad, M. G., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101896 · Cited by 148 · see citing works
Iron Homeostasis Disorder and Alzheimer’s Disease
Peng, Y., Chang, X., & Lang, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212442 · Cited by 143 · see citing works
Charkoudian, L. K., & Franz, K. J. (2006) · Inorganic Chemistry · doi:10.1021/ic060014r · Cited by 147 · see citing works
Jeong, S. Y., & David, S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2922-06.2006 · Cited by 148 · see citing works
Iron overload: Effects on cellular biochemistry
Nogueira, L. S., Oliveira, M. M., Pessoa, M. T., & Barbosa, L. A. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.029 · Cited by 144 · see citing works
Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Schneider, S. A., Dušek, P., Hardy, J., Westenberger, A., Jankovic, J. J., & Bhatia, K. P. (2013) · Current Neuropharmacology · doi:10.2174/157015913804999469 · Cited by 140 · see citing works
Iron, the substantia nigra and related neurological disorders
Snyder, A. M., & Connor, J. R. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.005 · Cited by 137 · see citing works
Structure and function of amyloid in Alzheimer's disease
Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 136 · see citing works
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects
Zucca, F. A., Giaveri, G., Gallorini, M., Albertini, A., Toscani, M., Pezzoli, G., Lucius, R., Wilms, H., Sulzer, D. L., Ito, S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00201.x · Cited by 134 · see citing works
Zucca, F. A., Bellei, C., Giannelli, S. G., Terreni, M., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., & Zecca, L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0453-2 · Cited by 132 · see citing works
Aluminum’s Involvement in the Progression of Alzheimer’s Disease
Walton, J. R. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121909 · Cited by 127 · see citing works
Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 126 · see citing works
Liu, Y., Kempf, V. R., Nofsinger, J. B., Weinert, E. E., Rudnicki, M. D., Wakamatsu, K., Ito, S., & Simon, J. D. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00059.x · Cited by 126 · see citing works
Metal imaging in neurodegenerative diseases
Bourassa, M. W., & Miller, L. M. (2012) · Metallomics · doi:10.1039/c2mt20052j · Cited by 122 · see citing works
Xu, Q., Kanthasamy, A. G., & Reddy, M. B. (2007) · Toxicology · doi:10.1016/j.tox.2007.12.017 · Cited by 121 · see citing works
Chen, H., Lukas, T. J., Du, N. Y., Suyeoka, G. M., & Neufeld, A. H. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2850 · Cited by 119 · see citing works
Role of iron in neurodegenerative diseases
Li, K., & Reichmann, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1508-7 · Cited by 118 · see citing works
Insights into Melanosomes and Melanin from Some Interesting Spatial and Temporal Properties
Simon, J. D., Hong, L., & Peles, D. N. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp804248h · Cited by 118 · see citing works
Modifications of the iron–neuromelanin system in Parkinson's disease
Fasano, M., Bergamasco, B., & Lopiano, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03638.x · Cited by 117 · see citing works
Iron and reactive oxygen species activity in parkinsonian substantia nigra
del Nogal, A. W., Gałązka-Friedman, J., Bauminger, E. R., Wszołek, Z. K., Schweitzer, K. J., Dickson, D. W., Jaklewicz, A., Elbaum, D., & Friedman, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.007 · Cited by 117 · see citing works
Faucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116 · see citing works
Zhang, X., Thompson, M., & Xu, Y.-H. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.161 · Cited by 116 · see citing works
Cheng, Z., He, N., Huang, P., Li, Y., Tang, R., Sethi, S. K., Ghassaban, K., Yerramsetty, K. K., Palutla, V. K., Chen, S., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102103 · Cited by 114 · see citing works
Gerlach, M., Double, K. L., Ben‐Shachar, D., Zecca, L., Youdim, M. B. H., & Riederer, P. F. (2003) · Neurotoxicity Research · doi:10.1007/bf03033371 · Cited by 112 · see citing works
Using High-Resolution MR Imaging at 7T to Evaluate the Anatomy of the Midbrain Dopaminergic System
Eapen, M., Zald, D. H., Gatenby, J. C., Ding, Z., & Gore, J. C. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2355 · Cited by 109 · see citing works
Suh, J., Moreau, R., Heath, S.-H. D., & Hagen, T. (2005) · Redox Report · doi:10.1179/135100005x21624 · Cited by 107 · see citing works
Brain iron accumulation in aging and neurodegenerative disorders
Hagemeier, J., Geurts, J. J. G., & Zivadinov, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.128 · Cited by 110 · see citing works
The Involvement of Iron in Traumatic Brain Injury and Neurodegenerative Disease
Daglas, M., & Adlard, P. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00981 · Cited by 111 · see citing works
Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
Doroszkiewicz, J., Farhan, J. A., Mroczko, J., Winkel, I., Perkowski, M., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115721 · Cited by 107 · see citing works
Impaired iron status in aging research
Xu, J., Jia, Z., Knutson, M. D., & Leeuwenburgh, C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13022368 · Cited by 103 · see citing works
Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI
Xing, Y., Sapuan, A. H., Dineen, R. A., & Auer, D. P. (2018) · Movement Disorders · doi:10.1002/mds.27502 · Cited by 103 · see citing works
The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
Joppe, K., Roser, A., Maass, F., & Lingor, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00015 · Cited by 102 · see citing works
Iron Metabolism in Aging and Age-Related Diseases
Tian, Y., Tian, Y., Yuan, Z., Zeng, Y., Wang, S., Fan, X., Yang, D., & Yang, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073612 · Cited by 104 · see citing works
Influence of neuromelanin on oxidative pathways within the human substantia nigra
Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00218-0 · Cited by 102 · see citing works
Genetics of iron regulation and the possible role of iron in Parkinson's disease
Rhodes, S. L., & Ritz, B. R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.001 · Cited by 99 · see citing works
Iron in neurodegenerative disorders
Berg, D., Becker, G., Riederer, P. F., & Rieß, O. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000045444 · Cited by 98 · see citing works
Disturbance of iron metabolism in Parkinson’s disease — ultrasonography as a biomarker
Berg, D., Hochstrasser, H., Schweitzer, K. J., & Rieß, O. (2006) · Neurotoxicity Research · doi:10.1007/bf03033302 · Cited by 98 · see citing works
Dopamine efflux by MPTP and hydroxyl radical generation
Obata, T. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-001-0683-2 · Cited by 96 · see citing works
Andreas Schäfer, A., Forstmann, B. U., Neumann, J., Wharton, S., Mietke, A., Bowtell, R. W., & Turner, R. (2011) · Human Brain Mapping · doi:10.1002/hbm.21404 · Cited by 96 · see citing works
Wise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D. L., Zecca, L., & Burbulla, L. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105920 · Cited by 95 · see citing works
Feng, S.-T., Wang, Z.-Z., Yuan, Y.-H., Sun, H.-M., Chen, N.-H., & Zhang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104336 · Cited by 96 · see citing works
Lü, L., Qian, Z., Wu, K.-C., Yung, W., & Ke, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0067-0 · Cited by 92 · see citing works
Book Review: Iron and Parkinson’s Disease
Wolozin, B. L., & Golts, N. (2002) · The Neuroscientist · doi:10.1177/107385840200800107 · Cited by 89 · see citing works
- Authors
- Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Pavia (IT)
- University of Lübeck (DE)
- University of Würzburg (DE)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2001-03-15
- Volume
- 76
- Issue
- 6
- Pages
- 1766-1773
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1601438958
- Cited by
- 401
- References
- 61
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 25 · 2020: 13 · 2019: 20 · 2018: 23 · 2017: 18 · 2016: 19 · 2015: 10 · 2014: 14 · 2013: 17 · 2012: 14
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Fondazione Cariplo
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- brain iron, substantia nigra, neuromelanin, ferritin, iron storage, aging, neurodegeneration, high-spin iron, postmortem brain
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Child, Child, Preschool, Ferritins, Humans, Infant, Iron, Melanins, Middle Aged, Nerve Degeneration, Reference Values, Substantia Nigra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review